Clinical trial: a novel high-dose 1 g mesalamine suppository (Salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples